European Directorate for the Quality of Medicines & HealthCare
Publisher of the European Pharmacopoeia and issuer of Certificates of Suitability (CEPs) for active substances supplied into Europe.
WHAT EDQM COVERS
The European Directorate for the Quality of Medicines & HealthCare is a directorate of the Council of Europe in Strasbourg — not an EU body, which is the single most common misunderstanding about it. It operates under the Convention on the Elaboration of a European Pharmacopoeia, and its central output is the European Pharmacopoeia: general chapters, general monographs, and specific monographs for substances and preparations. Alongside the compendium it runs the Certification of Suitability procedure, the network of Official Medicines Control Laboratories, and the supply of Ph. Eur. reference standards.
WHERE IT SITS INTERNATIONALLY
EDQM works with the European Medicines Agency and the national competent authorities, whose assessors rely on Ph. Eur. monographs as the quality reference during authorisation, and its OMCL network underpins independent batch control across Europe. Internationally it is one of the three participants in the Pharmacopoeial Discussion Group alongside the United States Pharmacopeia and the Japanese Pharmacopoeia, working toward harmonised general chapters and excipient monographs, and it contributes to the ICH Q4 work on pharmacopoeial harmonisation. The CEP procedure is its most exported mechanism: one EDQM assessment referenced by many applications, which is why non-European API manufacturers encounter EDQM long before they encounter any individual national regulator.
HOW ITS REQUIREMENTS BITE
Ph. Eur. monographs are legally binding in the states party to the Convention, and the European Union is itself a signatory party — so within the EU, compliance with the applicable monograph is a legal requirement rather than a recommendation, enforced through marketing-authorisation assessment and national GMP inspection. EDQM's own direct oversight is narrower and specific: it assesses and issues Certificates of Suitability, and it inspects CEP holders. A CEP can be suspended or withdrawn, and that action propagates immediately to every marketing authorisation referencing it.
WHAT EDQM PUBLISHES
- 01The European Pharmacopoeia — general chapters, general monographs, and specific monographs, revised through periodic supplements each with a fixed implementation date
- 02Certificates of Suitability to the Monographs of the European Pharmacopoeia (CEPs), referenceable in marketing-authorisation applications in place of a full active substance master file
- 03Pharmeuropa — the consultation forum where draft monographs and revisions are published for comment before adoption
- 04Ph. Eur. chemical and biological reference standards, which are the materials the compendial methods are actually calibrated against
- 05Guidance and technical guides for CEP applicants, and the OMCL network's quality-management and testing guidelines
WHAT PRACTITIONERS GET WRONG
- ›Confirm the current edition and supplement in force before citing a monograph — Ph. Eur. revises on a rolling schedule, and testing against a superseded monograph is a finding, not a technicality.
- ›General chapters and general monographs apply even where no specific monograph exists for your substance; assuming the absence of a specific monograph means no compendial requirement is a routine and expensive error.
- ›A CEP is route-specific and site-specific. Verify it covers the actual synthesis route and manufacturing site your material comes from, not merely the supplier's name, and monitor its status as part of periodic supplier review.
- ›Ph. Eur. and USP are only partially harmonised through the Pharmacopoeial Discussion Group — assume a method, limit, or reference standard differs until you have compared them, particularly for products supplied to both markets.
- ›EDQM belongs to the Council of Europe, so Ph. Eur. membership extends beyond the EU; a manufacturer supplying a signatory state outside the EU is still bound by the monograph.
EDQM STANDARDS SPEQ DECODES · 2
DISCIPLINES IN EDQM’S REMIT
Track EDQM — and every regulator that matters
New rules, guidance, enforcement, and inspection signals from European Directorate for the Quality of Medicines & HealthCare and its peers worldwide, distilled into the free Weekly GxP Briefing.